Rising Beta Blocker Use for Anxiety Sparks Concern Among Experts
A growing trend of using beta blockers for anxiety, fueled by celebrity endorsements, is raising concerns among medical professionals regarding potential risks and limited evidence of effectiveness. While traditionally prescribed for heart conditions, the medication is increasingly sought after for managing situational anxiety, despite not being recommended for this purpose by leading health organizations.
One doctor cautioned, “But, it is not without risk,” as reported by The Wall Street Journal. Prescriptions for anti-anxiety medications have seen a significant increase in recent years, particularly among women and young people reporting higher rates of anxiety disorders. This rise coincides with a broader trend of medications gaining popularity through cultural influence, inevitably leading too increased prescriptions.
Researchers at the university of Bristol’s medical school found a potentially troubling perception among patients: many did not view beta blockers as “mental health drugs,” leading them to believe the medication carried less stigma. This perception may contribute to its appeal as a swift fix for anxiety.
Despite anecdotal evidence – including actress Khloe Kardashian admitting to using her mother Kris Jenner’s beta blockers to manage nerves – experts emphasize a lack of conclusive evidence supporting their effectiveness in treating anxiety. The medication is also not included in treatment guidance from the National Institute for Health and Care Excellence (NICE), yet prescriptions continue to be written.
Dr. Khan explained that many GPs prescribe beta blockers for situational anxiety – specifically for events a patient anticipates will be triggering. “So if and when, rather than long term,” he clarified.
While beta blockers can be life-saving for individuals with heart conditions, their primary effects can present risks. Common side effects include tiredness, dizziness, and difficulty sleeping. More serious risks encompass heart failure, breathing difficulties, and allergic reactions.Dr. Khan also warned against exceeding prescribed dosages, noting that abruptly stopping the medication after prolonged use can be hazardous. Moreover, he highlighted a link between beta blocker use and higher rates of depression, advising against prescribing them to patients already struggling with the condition.
Recent research adds to these concerns. A landmark study suggests that heart attack patients may be needlessly taking beta blockers, and the drug could even increase the risk of death. Approximately 60,000 people in the UK are prescribed beta blockers annually, with many remaining on the medication for life. However, the new research indicates the medication is ineffective in reducing the risk of further heart attacks.
Notably, the study found women treated with beta blockers had a higher risk of death, heart attacks, or hospitalization for heart failure compared to those not taking the medication.This finding casts further doubt on the widespread and long-term use of beta blockers,particularly considering the emerging trend of self-medication for anxiety.
